|
||||
| HOME | ABOUT US | PIPELINE | R & D | PUBLICATIONS | PARTNERING | INVESTORS | CAREERS | CONTACT | ||||
|
|
|
|||
|
Anavex Life Sciences Corp. (OTC BB: AVXL) is pleased to announce that it will be a presenting company at the Rodman & Renshaw Annual Global Investment Conference, held on September 12 to 15, 2010 in New York, NY, USA at the New York Palace Hotel. Dr. Cameron Durrant, Anavex’s Executive Chairman, will be speaking at the 12th Annual Healthcare Conference — a specific industry segment of the Rodman & Renshaw program. Dr. Durrant takes the spotlight on Monday, September 13, 2010 from 4:55 p.m. to 5:20 p.m. ET in the Spellman Salon (5th floor). This is a must see presentation as Dr. Durrant will discuss the “first of a new class of therapies for Alzheimer’s disease.” The high profile conference is tailored to institutional investors, venture capitalists, private equity firms, business development executives and sophisticated private investors. In addition to corporate presentations and question-and-answer sessions, the one-on-one investor meetings offer exceptional networking opportunities for both delegates and attendees. Registration for the conference can be made online by visiting www.rodm.com or contacting Ms. Lily Khaykina, Rodman & Renshaw’s Conference Manager, at (212) 430-1714 or via e-mail at LK@rodm.com. Anavex looks forward to meeting you in New York!
About the Venue: The New York Palace Hotel
About Rodman & Renshaw, LLC: |
||||
| © 2007-2011 Anavex Life Sciences Corp. - All Rights Reserved. | ||||